Last reviewed · How we verify

NCT03525340

Improving Health Outcomes for Women Living With HIV

Completed NA Last updated 22 November 2019
What this trial tests

NA trial testing Peer Navigation in HIV/AIDS in 113 participants. Completed in 15 October 2019.

Timeline
7 May 2018
Primary endpoint
15 October 2019
15 October 2019

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment113
Start date7 May 2018
Primary completion15 October 2019
Estimated completion15 October 2019
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, male only, with HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will develop and conduct a trans-specific peer navigation intervention in Brazil, which integrates the I-Care approach developed in South Africa with the Model of Gender Affirmation (GA), developed by the investigators to specifically address HIV prevention and care among trans women.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Correlation between gender-based violence and poor treatment outcomes among transgender women living with HIV in Brazil.
    de Sousa Mascena Veras MA, Menezes NP, Mocello AR, Leddy AM, et al · · 2024 · cited 7× · PMID 38481195 · DOI 10.1186/s12889-024-18224-3
  2. Sexual violence is associated with poor treatment outcomes among transgender women living with HIV in Brazil
    Leddy AM, Veras MAdSM, Saggese GSR, Bassichetto KC, et al · · 2022 · DOI 10.21203/rs.3.rs-2143250/v1

Verify or expand the search:

Other trials of Peer Navigation

Trials testing the same drug.

Other recruiting trials for HIV/AIDS

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525340.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing